1994•PubMedRequires access

[Quality of life in patients with acute myeloid leukemia].

Anita Schumacher

Open publisher page 1 citations

Abstract

BACKGROUND: In oncology, quality of life has become an essential criterion for evaluating the effects of therapy in clinical trials. So far, in adult patients suffering from acute leukemia assessment of quality of life has not been considered possibly due to poor prognosis and the acute course of the disease. Advances in chemotherapy significantly prolong survival of patients with acute myeloid leukemia and may cure a subset of patients. Therefore, the assessment of quality of life of patients undergoing treatment is of growing interest. PATIENTS AND METHOD: The following article will discuss the concept and theoretical frame-work of a study designed to evaluate quality of life in adult patients with acute myeloid leukemia undergoing chemotherapy. RESULT: Preliminary results show the psychooncological relevance of the study for the clinician.

About this research paper

What this paper is about

BACKGROUND: In oncology, quality of life has become an essential criterion for evaluating the effects of therapy in clinical trials. So far, in adult patients suffering from acute leukemia assessment of quality of life has not been considered possibly due to poor prognosis and the acute course of the disease. Advances in chemotherapy significantly prolong survival of patients with acute myeloid leukemia and may cure a subset of patients. Therefore, the assessment of quality of life of patients undergoing treatment is of growing interest. PATIENTS AND METHOD: The following article will discuss the concept and theoretical frame-work of a study designed to evaluate quality of life in adult patients with acute myeloid leukemia undergoing chemotherapy. RESULT: Preliminary results show the psychooncological relevance of the study for the clinician.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

BACKGROUND: In oncology, quality of life has become an essential criterion for evaluating the effects of therapy in clinical trials. So far, in adult patients suffering from acute leukemia assessment of quality of life has not been considered possibly due to poor prognosis and the acute course of the disease. Advances in chemotherapy significantly prolong survival of patients with acute myeloid leukemia and may cure a subset of patients. Therefore, the assessment of quality of life of patients undergoing treatment is of growing interest. PATIENTS AND METHOD: The following article will discuss the concept and theoretical frame-work of a study designed to evaluate quality of life in adult patients with acute myeloid leukemia undergoing chemotherapy. RESULT: Preliminary results show the psychooncological relevance of the study for the clinician.

Key concepts: Medicine, Myeloid leukemia, Quality of life (healthcare), Intensive care medicine, Chemotherapy, Oncology, Disease, Leukemia

Related papers

Back to paper searchBrowse research topicsOriginal source